FY26 Results Presentation

Key points

• FY26 revenue up 3% to $7.74m
• Gross margin improved by 2%
• Positive EBITDA of $1.08m
• Strong cash position of $2.57m
• Marketplace revenue increased by 73% YoY

Full summary

Pharmx Technologies Ltd announced its FY26 results, showing a revenue increase of 3% to $7.74m, with gross margin improving by 2%. The company reported a positive EBITDA of $1.08m and maintained a strong cash position of $2.57m. The marketplace revenue saw a significant increase of 73% year-over-year, contributing to the overall growth. The company also highlighted its strategic initiatives for FY27, including scaling marketplace growth, expanding margins, and modernizing its EDI services.

Guidance

FY27 revenue expected to exceed $100m annualized GTV run rate

Outlook

Pharmx Technologies expects to convert FY26's strong financial performance into growth in FY27, with a focus on scaling marketplace, expanding margins, and modernizing EDI services.